Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept 50 mg QW vs 25 mg BIW in Ankylosing Spondylitis
NCT00418548Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2004
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in ankylosing spondylitis (AS), sponsored by Pfizer. Started Jun 2004; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00418548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418548.